Pfizer raises full-year outlook as newer products grow, names veteran as new CFO
Pfizer raises full-year outlook as newer products grow, names veteran as new CFO
Pfizer raises full-year outlook as newer products grow, names veteran as new CFO
Key points
اہم نکات
मुख्य बातें
- Pfizer has raised its full-year outlook as growth from its newer products gathers pace.
- The drugmaker also named a company veteran as its new chief financial officer, a leadership change aimed at steering its next phase of growth.
- Pfizer has raised its full-year outlook as growth from its newer products gathers pace.
- The drugmaker also named a company veteran as its new chief financial officer, a leadership change aimed at steering its next phase of growth.
- Pfizer has raised its full-year outlook as growth from its newer products gathers pace.
- The drugmaker also named a company veteran as its new chief financial officer, a leadership change aimed at steering its next phase of growth.
Pfizer has raised its full-year outlook as growth from its newer products gathers pace. The drugmaker also named a company veteran as its new chief financial officer, a leadership change aimed at steering its next phase of growth.
Pfizer has raised its full-year outlook as growth from its newer products gathers pace. The drugmaker also named a company veteran as its new chief financial officer, a leadership change aimed at steering its next phase of growth.
Pfizer has raised its full-year outlook as growth from its newer products gathers pace. The drugmaker also named a company veteran as its new chief financial officer, a leadership change aimed at steering its next phase of growth.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।